Tag: SARS-CoV-2
Browse our exclusive articles!
AstraZeneca vax linked to rare neurological disorder in India, England
Eleven individuals who received the AstraZeneca-Oxford Covid-19 vaccine have developed a rare neurological disorder called Guillain-Barre syndrome, clinicians in India and England have reported...
Explained: How oxygen levels decline in Covid-19 patients
SARS-CoV-2, the virus causing Covid-19, infects immature red blood cells (RBC), reducing oxygen in the blood and impairing the immune response, say, researchers.
The study,...
California Covid variant can re-infect people: Study
A team of US researchers has found how a coronavirus variant that had emerged in California interacts with the immune system and its potential...
IIT Mandi reveals a key protein structure in Covid virus
A team of researchers from the Indian Institute of Technology Mandi (IIT Mandi) has elucidated the part of the structure of a key protein...
DRDO develops Covid-19 antibody detection kit
The Defence Research and Development Organisation (DRDO) has developed an antibody detection kit known as Dipcovan, which is expected to be available at Rs...
Covid-19 can infect cells in eye: Study
A team of US researchers has, in an alarming study, found direct evidence that Covid-19 can infect cells in the eye.
SARS-CoV-2, which causes Covid-19,...
New vaccine blocks Covid-19, variants, other Coronaviruses
US researchers have developed a potential new vaccine, which has proven effective against the original SARS-CoV-1, SARS-CoV-2 as well as its UK, South Africa,...
Rs 15 cr still needed to take IISc’s vax studies further
The Covid-19 pandemic has not just battered the healthcare sector, but it has also resulted in a financial crisis across sectors.
Syntax, a startup incubated...
Coronavirus’ spike protein alone may cause lung damage: Study
A team of researchers in the US have found that exposure to the SARS-CoV-2 spike protein alone was enough to induce Covid-19-like symptoms, including...
Biological E Covid vaccine candidate gets CDSCO nod for Phase III trials
Hyderabad-based vaccine and pharmaceutical company Biological E. Limited (BE) announced on Saturday that its Covid-19 subunit vaccine candidate has received approval to begin Phase...